Research Topics
| Marie Paule KienySummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
A global pandemic influenza vaccine action planMarie Paule Kieny
World Health Organization, Geneva, Switzerland
Vaccine 24:6367-70. 2006..2) To strengthen the engagement and collaboration of key partners and stakeholders...- The promise of conjugate vaccines for AfricaMarie Paule Kieny
Initiative for Vaccine Research, World Health Organization, Av Appia 20, 1211 Geneva 27, Switzerland
Vaccine 25:A108-10. 2007..A review of the evidence in order to analyse how to optimize immunization schedules for conjugate vaccines is warranted... 
Research and development of new vaccines against infectious diseasesMarie Paule Kieny
Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, CH1211 Genève 27, Switzerland
Am J Public Health 94:1931-5. 2004..The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible...- [Malaria vaccines: state of advancement]M P Kieny
WHO/IVR, 20 Avenue Appia, , Suisse
Med Trop (Mars) 63:245-6. 2003 - Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccineChristopher B Nelson
Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
Am J Public Health 97:S15-22. 2007..It will remain so for the foreseeable future and until appropriate and affordable conjugate vaccines become part of national immunization programs in the region... 
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transferMartin Friede
World Health Organization, Avenue Appia, 1211 Geneva, Switzerland
Vaccine 29:A2-7. 2011..This supplement of Vaccine is devoted to showcasing the interim results of the WHO initiative and the impressive progress made by the developing country manufacturers...- Human vaccine research and development: an overviewMarie Paule Kieny
Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, , Switzerland
Vaccine 23:5705-7. 2005..Importantly, developing countries should be empowered to participate actively in the development and introduction of new vaccines according to their national priorities... - Reducing empiricism in malaria vaccine designVasee S Moorthy
World Health Organization, Geneva, Switzerland
Lancet Infect Dis 10:204-11. 2010.... - Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbitsZarifah Hussain Reed
Initiative for Vaccines Research, World Health Organization, Geneva, Switzerland
Vaccine 27:1651-60. 2009..Data from this study can assist in making decisions for further clinical development of MSP1-based candidates, and this process sets a precedent for future comparisons of malaria vaccine candidates... - Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, ThailandJ Hombach
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
Vaccine 23:2689-95. 2005.... - Malaria vaccine development: progress and challengesZ H Reed
Initiative for Vaccine Research, World Health Organization, Department of Immunizations, Vaccines and Biologicals, 20 Avenue Appia, CH 1211 Geneva, Switzerland
Curr Mol Med 6:231-45. 2006..Therefore, it is critical that the main challenges to malaria vaccine development be unambiguously identified and collectively addressed... - Immunization safety priority project at the World Health OrganizationPhilippe Duclos
Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization Geneva, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
Semin Pediatr Infect Dis 14:233-9. 2003..The project emphasizes the importance of advocating safety and building capacity at national levels... - Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targetsJeffrey Partridge
Initiative for Vaccine Research, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
Vaccine 28:4709-12. 2010.... - Research agenda for mass gatherings: a call to actionJohn S Tam
Initiative for Vaccine Research, Family, Women s and Children s Health Cluster, WHO, Geneva, Switzerland
Lancet Infect Dis 12:231-9. 2012..Implementation of the proposed research topics would be expected to provide benefits over the medium to long term in planning for MGs... - Cholera in disasters: do vaccines prompt new hopes?Claire Lise Chaignat
Global Task Force on Cholera Control, Department of Neglected Tropical Diseases, Communicable Diseases Cluster, World Health Organization, 20, Av Appia, 1211 Geneva 27, Switzerland
Expert Rev Vaccines 7:431-5. 2008..Following these two campaigns, WHO recommendations on the use of oral cholera vaccines in complex emergencies were issued in 2006... - Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Santé, Fondation Mérieux, Annecy, France, 7-9 January 2002Howard Engers
World Health Organization/IVR, Avenue Appia 20, CH-1211, Geneva 27, Switzerland
Vaccine 21:3503-24. 2003 - First generation leishmaniasis vaccines: a review of field efficacy trialsSassan Noazin
World Health Organization, CH1211, Geneva 27, Switzerland
Vaccine 26:6759-67. 2008..To provide a collective view, this review discusses the methods and findings of field efficacy trials of first generation leishmaniasis vaccine clinical trials conducted in the Old and New Worlds... - A review of human vaccine research and development: malariaMarc P Girard
University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
Vaccine 25:1567-80. 2007..This article attempts to summarize the state of the art of malaria vaccine development... - Development and evaluation of influenza pandemic vaccinesIain Stephenson
Lancet Infect Dis 6:71-2. 2006 - Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008Marc Girard
University Paris-Diderot, Lyon, France
Vaccine 26:4975-7. 2008 - A review of vaccine research and development: human acute respiratory infectionsMarc P Girard
University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France
Vaccine 23:5708-24. 2005..This article reviews the state of the art in vaccine R&D against ARIs and attempts to address these basic public health questions... - A review of vaccine research and development: human enteric infectionsMarc P Girard
University Paris 7, UFR Biochemistry, 39 rue Seignemartin, 69008 Lyon, France
Vaccine 24:2732-50. 2006..This article reviews the state of the art in vaccine R&D against human viral and bacterial enteric infections of public health importance... - The impact of globalization on vaccine development and availabilityJulie B Milstien
Center for Vaccine Development, Department of Geographic Medicine, University of Maryland School of Medicine, USA
Health Aff (Millwood) 25:1061-9. 2006..All of these forces can affect, either positively and negatively, the development and availability of vaccines. Harnessing these will be a challenge for policymakers and immunization stakeholders... - Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007Marc P Girard
University Paris-Diderot, Lyon, France
Vaccine 26:2443-50. 2008 - A review of vaccine research and development: the human immunodeficiency virus (HIV)Marc P Girard
University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
Vaccine 24:4062-81. 2006..This article reviews the state of the art in HIV vaccine development, summarizes the results obtained so far and discusses the challenges to be met in the development of the various vaccine candidates... - A review of vaccine research and development: meningococcal diseaseMarc P Girard
University Paris 7, 39 rue Seignemartin, FR 69008 Lyon, France
Vaccine 24:4692-700. 2006..However, effective global prevention of meningococcal disease will not be achievable without the development of a vaccine against Group B meningitis, for which outer membrane protein vaccines are under development... - Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005Alan W Hampson
Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
Vaccine 24:4897-4900. 2006..The main conclusions and recommendations from this consultation are presented below... - Different approaches to influenza vaccinationKeiji Fukuda
N Engl J Med 355:2586-7. 2006 - Development of vaccines against influenza H5Iain Stephenson
Lancet Infect Dis 6:458-60. 2006